Similar Articles
1341 Biological features and biomarkers in hepatocellular carcinoma
1342 Optimal combination of antiangiogenic therapy for hepatocellular carcinoma
1343 Neoplastic disease after liver transplantation: Focus on de novo neoplasms
1344 Transcatheter arterial infusion for advanced hepatocellular carcinoma: Who are candidates?
1345 Current and future treatments for hepatocellular carcinoma
1346 Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma
1347 Selection tool alpha-fetoprotein for patients waiting for liver transplantation: How to easily manage a fractal algorithm
1348 Current management of patients with hepatocellular carcinoma
1349 Mechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapy
1350 Perspective of laparoscopic liver resection for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA